PharmEasy Annual Reports, and API Holding Financials

Particulars

31-03-2024

31-03-2023

Non-current assets

Property, plant and equipment

2,862.44

3,378.97

Right-of-use assets

1,385.84

1,541.02

Capital work-in-progress

27.56

30.63

Goodwill

36,911.84

42,699.35

Other intangible assets

4,474.21

5,742.05

Intangible assets under development

9.48

10.74

Investments accounted for using the equity method

1,748.03

2,016.06

Investments

174.62

173.62

Other financial assets

249.95

353.17

Deferred tax assets (net)

426.98

219.18

Non - current tax assets (net)

758.44

844.92

Other non-current assets

104.68

205.82

Current assets

Inventories

5,555.60

6,881.60

Investments

1,367.55

1,232.37

Trade receivables

7,062.10

9,050.34

Cash and cash equivalents

3,279.89

1,936.48

Other bank balances

12,825.02

1,038.69

Loans

695.58

1,171.28

Other financial assets

862.62

920.24

Other current assets

3,071.28

3,116.49

Assets classified as held for sale

42.89

1.14

Total assets

83,896.60

82,564.16

Equity

Equity Share capital

6,240.44

6,142.04

Instruments entirely in the nature of equity

256.53

-

Equity component of compound financial instruments

78.90

78.9

Reserves and surplus

15,568.55

14,703.77

Non-controlling interests

3,738.68

3,444.18

Non-current liabilities

Borrowings

20,243.92

32,009.08

Lease liabilities

900.39

1,028.72

Provisions

111.66

131.36

Deferred tax liabilities (net)

1,732.70

1,793.71

Contract liabilities

-

0.17

Current liabilities

Borrowings

20,739.65

9,190.76

Lease liabilities

310.25

333.82

Trade payables

Total outstanding dues of micro and small enterprises

322.97

181.25

Total outstanding dues of other than micro and small enterprises

3,806.10

3,952.86

Other financial liabilities

7,752.28

7,473.88

Other current liabilities

1,618.82

1,491.32

Contract liabilities

130.79

141.7

Provisions

302.91

366.24

Current tax liabilities (net)

41.06

100.4

Total equity and liabilities

83,896.60

82,564.16

Particulars

31-03-2024

31-03-2023

Income

Revenue from operations

56,642.86

66,439.38

Other income

946.55

558.33

Total income

57,589.41

66,997.71

Expenses

Cost of Material Consumed

1,645.09

1,569.20

Purchase of stock-in-trade

45,728.06

55,120.60

Changes in inventories of stock-in-trade

1,430.14

618.96

Employee benefits expense

6,993.63

12,833.20

Finance costs

7,279.16

6,655.43

Depreciation and amortization expense

2,159.52

2,434.40

Expected credit loss on financial assets

1,692.64

Other expenses

5,619.76

10,508.31

Total expenses

72,548.00

89,740.10

Loss before exceptional items, share of net profit/(loss) of Investments accounted for using the equity method and tax

-14,958.59

-22,742.39

Share of profit/(loss) of Investments accounted for using the equity method

8.75

-2.99

Loss before exceptional items and tax

-14,949.84

-22,745.38

Impairment of goodwill

-5,825.00

-28,256.10

Impairment of investments in associates

-334.25

-963.74

Early redemption charges for NCD 's

-3,424.94

-

Others

-685.69

-

Loss before tax

-25,219.72

-51,965.22

Current tax

379.21

389.48

Deferred tax charge / (credit)

-270.03

-241.11

Tax expense pertaining to prior periods

6.23

3.75

Loss after tax

-25,335.13

-52,117.34

Other comprehensive income

Items that will not be reclassified to profit and loss

Remeasurements of post-employment defined benefit plans

24.64

97.95

Income tax relating to above items

-1.22

-6.22

Other comprehensive income, net of tax

23.42

91.73

Total comprehensive loss

-25,311.71

-52,025.61

Profit/(loss) for the period attributable to:

Owners of API Holdings Limited

-25,499.51

-52,295.46

Non controlling interest

164.38

178.12

Other comprehensive income / (loss) for the period attributable to:

-25,335.13

-52,117.34

Owners of API Holdings Limited

21.69

86.81

Non controlling interest

1.73

4.92

23.42

91.73

Total comprehensive income / (loss) for the period attributable to:

Owners of API Holdings Limited

-25,477.82

-52,208.65

Non controlling interest

166.11

183.04

Loss per share (face value of Rs. 1 each) attributable to owners of the group

Basic

-4.07

-8.51

Diluted

-4.07

-8.51

Particulars

31-03-2024

31-03-2023

Cash flow from operating activities

Loss before tax

-25,219.72

-51,965.22

Adjustments for :

Depreciation and Amortisation Expenses

2,159.52

2,434.40

Finance Costs

7,279.16

6,655.43

Early redemption charges for NCD 's

3,424.94

-

Net loss on disposal of property, plant and equipment

109.66

72.91

Gain on fair valuation of financial instruments measured at fair value through profit and loss (net)

-96.25

-107.35

Gain on sale of financial assets measured at fair value through profit and loss (net)

-0.14

-8.13

Impairment of goodwill

5,825.00

28,256.10

Impairment of investments accounted for using the equity method

334.25

963.74

Impairment of property, plant and equipment and lntangibles

426.99

-

Loss on fair value of assets held for sale

60.00

-

Gain on termination /modification of leases

-45.85

-94.24

Liabilities no longer required written back

-35

-72.97

Employee share based payment expense

2,218.52

6,237.50

Unwinding of interest on security deposits

-15.54

-19.04

Impairment allowance for doubtful advances and balances with government authorities

464.66

811.34

Expected credit loss on financial assets

1,692.64

683.37

Share of (profit) / loss of Investments accounted for using equity method

-8.75

2.99

Trade advances written off

-

5.01

Amortization of financial guarantee liability

-21.43

-16.49

Interest income

-689.80

-208.24

Operating (loss) before working capital changes

-2136.95

-6368.89

Changes in working capital:

(Increase)/decrease in other current and non-current financial assets

322.81

-71.05

(Increase)/decrease in other current and non-current assets

-318.29

250.76

(Increase)/decrease in trade receivables

295.60

-1,125.21

(Increase)/decrease in inventories

1,326.00

730.80

Increase/(decrease) in other current and non-current financial liabilities

204.77

-121.41

Increase/(decrease) in other current and non-current liabilities

127.51

341.06

Increase/(decrease) in trade payables

-5.04

-454.69

Increase/(decrease) in provisions

-59.61

21.76

Increase/(decrease) in contract liabilities

-11.08

-48.76

Cash used In operations

-250.28

-6,845.63

Income taxes paid (net of refund)

-357.08

-620.23

Net cash flow used In operating actlvltles

-611.36

-7,465.86

Cash flow from investing activities

Purchase of propeny, plant and equipment and intangible assets

-723.14

-951.57

Proceeds from sale of property, plant and equipment and intangible assets

101.57

79.58

Payments for purchase of investments (net)

-1,081.05

-39.10

Payments for purchase of mutual funds

-1,500.00

-1,810.40

Proceeds from sale of mutual funds

1,422.87

1,932.92

Loans and advances given

-54.30

-742.32

Proceeds from repayment of loans and advances given

530.00

126.40

Payment for placement affixed deposits with banks

-17,007.83

-

Proceeds from withdrawal of fixed deposits with banks

5,221.50

691.22

Interest received

543.37

138.12

Consideration paid for business acquisitions (net of cash and cash equivalents acquired)

-62.49

-135.62

Net cash flow used in investing activities

-12,609.50

-710.77

Cash flow from financing activities

Payment of share issue costs

-53.59

-

Proceed from issue of compulsorily convertible preference shares

20,000.80

5,483.47

Dividends paid to non-controlling interests

-295.08

-228.66

Proceeds from /Repayments of short term borrowings (net)

-2,102.32

-14,982.73

Repayment of long term borrowings

-494.31

-4,465.86

Proceeds from long term borrowings

286.29

25,970.79

Interest paid

-2,447.16

-2,795.46

Proceeds towards capital contribution by Non-Controlling Interest

12.24

-

Principal elements of lease payments

-338.54

-446.70

Net cash flow from financing activities

14,568.33

8,534.85

Net cash flows during the year

1,347.47

358.22

Cash and cash equivalents (opening balance)

1,926.98

1,568.76

Cash and cash equivalents (closing balance)

3,274.45

1,926.98

Particulars

2024

2023

Current Ratio

0.89

3.73

Debt-Equity ratio

0.6

0.01

Debt Service coverage ratio

-1.5

-7.14

Return on Equity Ratio

-1.11

-1.34

Inventory turnover ratio

7.57

8.29

Trade Receivables Turnover Ratio

11.34

13.05

Trade Payable Turnover Ratio

10.06

11.44

Net Capital Turnover Ratio

-2.28

1.67

Net Profit ratio

-4.2

-6.28

Return on Capital Employed (%)

-29%

-92%

Return on Investment (%)

-27%

-78%